Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors

The Wilms' tumor 1 gene, WT1, encodes a zinc‐finger protein that is implicated in the development of Wilms' tumor. Mutant or aberrantly expressed WT1 isoforms have also been described in desmoplastic small round cell tumor, acute leukemias, mesothelioma, breast tumors and melanoma. During early development, WT1 is expressed in the brain and spinal cord, however its role in the malignancies that affect these tissues has not been previously investigated. In our study we have examined neural tumors including brain tumors and neuroblastomas for WT1 expression and for mutations affecting the zinc‐fingers. Although WT1 expression was detected in gliomas, medulloblastomas and neuroblastomas, neither zinc‐finger region mutations nor splicing anomalies affecting the KTS site were detected. We therefore conclude that WT1 does not play a significant role in the etiology of human neural tumors. © 2001 Wiley‐Liss, Inc.

[1]  U. Gullberg,et al.  Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program , 1998, Oncogene.

[2]  Peter J. Smith,et al.  CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance , 1999, Journal of medical genetics.

[3]  C. Y. Wang,et al.  WT1 modulates apoptosis by transcriptionally upregulating the bcl‐2 proto‐oncogene , 1999, The EMBO journal.

[4]  E. Algar,et al.  Mutation analysis of the WT1 gene in sporadic childhood leukaemia , 1997, Leukemia.

[5]  Y. Oji,et al.  Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). , 1999, Leukemia research.

[6]  Z. Wang,et al.  Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain. , 1999, Biochemical and biophysical research communications.

[7]  J. Bard,et al.  The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo , 1993, Mechanisms of Development.

[8]  V. Sukhatme,et al.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Oji,et al.  Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth , 1999, Japanese journal of cancer research : Gann.

[10]  F. Rauscher,et al.  Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. , 1996, Nucleic acids research.

[11]  D. Haber,et al.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. , 1995, The EMBO journal.

[12]  M. Little,et al.  A clinical overview of WT1 gene mutations , 1997, Human mutation.

[13]  W. Gerald,et al.  Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Smith,et al.  Zinc finger point mutations within the WT1 gene in Wilms tumor patients. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Bertelmann,et al.  Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens , 2000, Journal of Cancer Research and Clinical Oncology.

[16]  W. Gerald,et al.  The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin , 1999, Cell.

[17]  E. Algar,et al.  Overexpression of murine WT1 + / + and - / - isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line. , 2000, Leukemia research.

[18]  J. Licht,et al.  E-cadherin Is a WT1 Target Gene* , 2000, The Journal of Biological Chemistry.

[19]  David Housman,et al.  WT-1 is required for early kidney development , 1993, Cell.

[20]  Amy Bernard,et al.  The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma , 1993, Nature Genetics.

[21]  P. Smith,et al.  A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. , 1996, Oncogene.

[22]  A. Jochemsen,et al.  Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.